Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1235619

registered interest
date	17/09/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of patients of child and adult mental health services administered by the NHS have (a) fetal valproate spectrum disorder, (b) fetal valproate syndrome, (c) fetal anti-convulsant syndrome and (d) autistic spectrum disorder primarily caused by valproate in pregnancy.
tabling member constituency	Stalybridge and Hyde
tabling member printed	Jonathan Reynolds
uin	91640
answer	answer is ministerial correction date of answer 25/09/2020 answer text <p>We are not able to provide this information as data is not held on all patients with fetal valproate spectrum disorder, fetal valproate syndrome, fetal anti-convulsant syndrome and autistic spectrum disorder.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 25/09/2020 14:58:07 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4119 label Biography information for Jonathan Reynolds

1235620

registered interest
date	17/09/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the time taken for his Department to investigate the effects of valproate in pregnancy; and whether he plans to launch an independent review of that matter.
tabling member constituency	Stalybridge and Hyde
tabling member printed	Jonathan Reynolds
uin	91641
answer	answer is ministerial correction date of answer 25/09/2020 answer text <p>The report of the Independent Medicines and Medical Devices Safety Review was published on 8 July and one of the interventions it considered was sodium valproate. The Government has received the report and is carefully considering its recommendations. An update will be provided in due course.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) is developing a valproate registry, which aims to monitor the use of valproate in girls and women in the United Kingdom, and to identify and monitor outcomes in any children born to women on valproate as well as ensuring compliance with the current regulatory requirements. There has been a gradual decline in prescribing of valproate to women of childbearing age over several years, and the MHRA is working with the National Health Service and professional regulators to ensure that women with epilepsy receive the healthcare they require.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 25/09/2020 14:52:55 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4119 label Biography information for Jonathan Reynolds